MX337439B - Suspensiones novedosas de nanocristales bimetalicos basados en oro-platino, procedimientos de fabricacion electroquimica para las mismas y sus usos. - Google Patents
Suspensiones novedosas de nanocristales bimetalicos basados en oro-platino, procedimientos de fabricacion electroquimica para las mismas y sus usos.Info
- Publication number
- MX337439B MX337439B MX2013011245A MX2013011245A MX337439B MX 337439 B MX337439 B MX 337439B MX 2013011245 A MX2013011245 A MX 2013011245A MX 2013011245 A MX2013011245 A MX 2013011245A MX 337439 B MX337439 B MX 337439B
- Authority
- MX
- Mexico
- Prior art keywords
- suspensions
- metal
- bimetallic
- platinum
- gold
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/242—Gold; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
- B82B1/00—Nanostructures formed by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
- B82B3/00—Manufacture or treatment of nanostructures by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
- B82B3/0009—Forming specific nanostructures
-
- C—CHEMISTRY; METALLURGY
- C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
- C22C—ALLOYS
- C22C30/00—Alloys containing less than 50% by weight of each constituent
-
- C—CHEMISTRY; METALLURGY
- C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
- C22C—ALLOYS
- C22C5/00—Alloys based on noble metals
- C22C5/02—Alloys based on gold
-
- C—CHEMISTRY; METALLURGY
- C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
- C22C—ALLOYS
- C22C5/00—Alloys based on noble metals
- C22C5/04—Alloys based on a platinum group metal
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Metallurgy (AREA)
- Mechanical Engineering (AREA)
- Materials Engineering (AREA)
- Nanotechnology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Manufacturing & Machinery (AREA)
- Manufacture Of Metal Powder And Suspensions Thereof (AREA)
- Powder Metallurgy (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161469525P | 2011-03-30 | 2011-03-30 | |
| PCT/US2012/031654 WO2012135743A2 (en) | 2011-03-30 | 2012-03-30 | Novel gold-platinum based bi-metallic nanocrystal suspensions, electrochemical manufacturing processes therefor and uses for the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2013011245A MX2013011245A (es) | 2013-10-17 |
| MX337439B true MX337439B (es) | 2016-03-03 |
Family
ID=46932416
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2013011245A MX337439B (es) | 2011-03-30 | 2012-03-30 | Suspensiones novedosas de nanocristales bimetalicos basados en oro-platino, procedimientos de fabricacion electroquimica para las mismas y sus usos. |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US9387225B2 (enExample) |
| EP (1) | EP2691082B1 (enExample) |
| JP (1) | JP6121985B2 (enExample) |
| KR (2) | KR102103534B1 (enExample) |
| CN (1) | CN103764123B (enExample) |
| BR (1) | BR112013025112A2 (enExample) |
| CA (1) | CA2829095C (enExample) |
| DK (1) | DK2691082T3 (enExample) |
| ES (1) | ES2564672T3 (enExample) |
| IL (1) | IL228356A (enExample) |
| MX (1) | MX337439B (enExample) |
| PH (1) | PH12013501954A1 (enExample) |
| RU (1) | RU2617055C2 (enExample) |
| SG (1) | SG193439A1 (enExample) |
| WO (1) | WO2012135743A2 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103757663A (zh) * | 2007-07-11 | 2014-04-30 | Gr智力储备股份有限公司 | 用于处理液体以及在液体中制造某些组分例如纳米粒的连续方法、装置以及获得的纳米粒和纳米粒/液体溶液 |
| EP2735389A1 (de) * | 2012-11-23 | 2014-05-28 | Universität Duisburg-Essen | Verfahren zur Herstellung reiner, insbesondere kohlenstofffreier Nanopartikel |
| JP5891320B1 (ja) * | 2015-02-12 | 2016-03-22 | 秋田県 | ゼータ電位制御法を用いた処理方法 |
| CN106680450B (zh) * | 2017-03-23 | 2023-04-25 | 江西省农业科学院农业经济与信息研究所 | 水质监测装置及方法 |
| US11674234B1 (en) * | 2020-09-30 | 2023-06-13 | National Technology & Engineering Solutions Of Sandia, Llc | Electrodeposited platinum-gold alloy |
| CN112683710B (zh) * | 2020-12-02 | 2024-04-16 | 大连理工大学 | 一种氯离子侵蚀下钢筋混凝土桥板加速腐蚀的试验装置 |
| CN112935273A (zh) * | 2021-01-26 | 2021-06-11 | 哈尔滨理工大学 | 一种室温制备CuPt合金纳米颗粒的方法 |
| JP2022131579A (ja) | 2021-02-26 | 2022-09-07 | キオクシア株式会社 | 分析装置および分析方法 |
| CN113500199B (zh) * | 2021-06-10 | 2022-11-08 | 浙江大学 | 一种基于金铂双金属活性氧自生成纳米材料的制备方法及其产品和应用 |
| CN113777034B (zh) * | 2021-08-20 | 2024-04-19 | 嘉兴学院 | 金纳米双锥阵列基底及其制备方法和应用 |
| CN114470201B (zh) * | 2021-12-24 | 2024-03-19 | 上海市儿童医院 | 一种装载kcna5抗体的金铂纳米颗粒及其制备方法和应用 |
| CN120504491B (zh) * | 2025-07-21 | 2025-09-16 | 景德镇学院 | 一种稳定陶瓷釉料烧制发色的添加剂及其方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5074652B2 (ja) | 2000-02-08 | 2012-11-14 | ライスユニバーシティ | 治療法および診断法において使用される光学活性なナノ粒子 |
| US7001617B2 (en) * | 2001-04-23 | 2006-02-21 | Nueryst Pharmaceuticals Corp. | Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals |
| US6989157B2 (en) | 2000-07-27 | 2006-01-24 | Nucryst Pharmaceuticals Corp. | Dry powders of metal-containing compounds |
| JP2002212102A (ja) | 2001-01-23 | 2002-07-31 | Ainobekkusu Kk | 電気化学的生理活性微粒子 |
| AU2002249046A1 (en) * | 2001-04-23 | 2002-11-05 | Nucryst Pharmaceuticals Corp. | Lubricious coatings for substrates |
| WO2005102019A2 (en) * | 2004-04-26 | 2005-11-03 | Cap Technologies, Llc | Treatment of fluids and/or sludge with electro plasma |
| TW200704404A (en) * | 2005-03-23 | 2007-02-01 | Shetech Co Ltd | Precious metal nanocolloid solution |
| JP2009522099A (ja) * | 2006-01-03 | 2009-06-11 | ジーアール インテレクチュアル リザーブ リミティド ライアビリティ カンパニー | 液体をより高反応性にする方法及び装置 |
| KR100857389B1 (ko) * | 2006-06-30 | 2008-09-11 | (주)아모레퍼시픽 | Ａｐ-ｇｒｒ 펩티드 또는 ａｐ-ｇｒｒ 펩티드를 포함하는펩티드사슬 및 이를 포함하는 약물전달담체 |
| TW200819540A (en) | 2006-07-11 | 2008-05-01 | Genelux Corp | Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders |
| CN103757663A (zh) | 2007-07-11 | 2014-04-30 | Gr智力储备股份有限公司 | 用于处理液体以及在液体中制造某些组分例如纳米粒的连续方法、装置以及获得的纳米粒和纳米粒/液体溶液 |
| JP2011520769A (ja) * | 2007-09-21 | 2011-07-21 | サイトイミューン サイエンシズ インコーポレイテッド | ナノ治療コロイド金属組成物および方法 |
| CN102281975B (zh) * | 2009-01-15 | 2015-10-07 | Gr智力储备股份有限公司 | 用于处理液体以及在液体中制造某些组分(例如纳米粒)的连续、半连续和成批方法、装置以及获得的纳米粒和纳米粒/液体溶液和胶体 |
| BR112012000311B1 (pt) * | 2009-07-08 | 2021-12-21 | Clene Nanomedicine, Inc. | Nanocristais com base em ouro para tratamentos médicos e processos eletroquímicos para a fabricação dos mesmos |
| KR101090431B1 (ko) * | 2009-08-19 | 2011-12-07 | 삼성전기주식회사 | 금속 씨앗을 이용한 금속 나노입자의 제조 방법 및 금속 씨앗을 함유하는 금속 나노입자 |
-
2012
- 2012-03-12 PH PH1/2013/501954A patent/PH12013501954A1/en unknown
- 2012-03-30 WO PCT/US2012/031654 patent/WO2012135743A2/en not_active Ceased
- 2012-03-30 ES ES12764547.1T patent/ES2564672T3/es active Active
- 2012-03-30 JP JP2014502869A patent/JP6121985B2/ja active Active
- 2012-03-30 DK DK12764547.1T patent/DK2691082T3/en active
- 2012-03-30 KR KR1020197006058A patent/KR102103534B1/ko active Active
- 2012-03-30 MX MX2013011245A patent/MX337439B/es active IP Right Grant
- 2012-03-30 KR KR1020137028744A patent/KR101955735B1/ko active Active
- 2012-03-30 BR BR112013025112-3A patent/BR112013025112A2/pt not_active Application Discontinuation
- 2012-03-30 SG SG2013068861A patent/SG193439A1/en unknown
- 2012-03-30 CA CA2829095A patent/CA2829095C/en active Active
- 2012-03-30 US US14/008,931 patent/US9387225B2/en active Active
- 2012-03-30 RU RU2013148011A patent/RU2617055C2/ru active
- 2012-03-30 EP EP12764547.1A patent/EP2691082B1/en active Active
- 2012-03-30 CN CN201280016524.9A patent/CN103764123B/zh active Active
-
2013
- 2013-09-11 IL IL228356A patent/IL228356A/en active IP Right Grant
-
2016
- 2016-07-07 US US15/204,534 patent/US20160317578A1/en not_active Abandoned
-
2022
- 2022-03-30 US US17/708,253 patent/US20230172975A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| KR101955735B1 (ko) | 2019-03-07 |
| BR112013025112A2 (pt) | 2020-09-29 |
| CN103764123B (zh) | 2018-03-13 |
| US20140294963A1 (en) | 2014-10-02 |
| DK2691082T3 (en) | 2016-02-29 |
| KR20190027933A (ko) | 2019-03-15 |
| RU2617055C2 (ru) | 2017-04-19 |
| IL228356A (en) | 2017-04-30 |
| EP2691082B1 (en) | 2016-01-13 |
| CN103764123A (zh) | 2014-04-30 |
| CA2829095C (en) | 2019-08-27 |
| US20160317578A1 (en) | 2016-11-03 |
| CA2829095A1 (en) | 2012-10-04 |
| RU2013148011A (ru) | 2015-05-10 |
| US9387225B2 (en) | 2016-07-12 |
| KR20140020310A (ko) | 2014-02-18 |
| SG193439A1 (en) | 2013-10-30 |
| PH12013501954A1 (en) | 2013-11-25 |
| MX2013011245A (es) | 2013-10-17 |
| WO2012135743A2 (en) | 2012-10-04 |
| WO2012135743A3 (en) | 2014-05-01 |
| JP6121985B2 (ja) | 2017-04-26 |
| KR102103534B1 (ko) | 2020-04-23 |
| US20230172975A1 (en) | 2023-06-08 |
| EP2691082A4 (en) | 2015-06-24 |
| JP2014518847A (ja) | 2014-08-07 |
| ES2564672T3 (es) | 2016-03-28 |
| AU2012236213A2 (en) | 2014-01-23 |
| EP2691082A2 (en) | 2014-02-05 |
| AU2012236213A1 (en) | 2013-11-14 |
| IL228356A0 (en) | 2013-12-31 |
| NZ617018A (en) | 2015-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12013501954A1 (en) | Novel gold-platinum based bi-metallic nanocrystal suspensions, electrochemical manufacturing processes therefor and uses for the same | |
| MX2023013237A (es) | Nanocristales novedosos basados en oro para tratamientos medicos y procedimientos de fabricacion electroquimica para los mismos | |
| MX2026002469A (es) | Nuevas moleculas de acido nucleico artificiales | |
| MY147658A (en) | Precipitated silica materials exhibiting high compatibility with cetylpyridinium chloride | |
| MX2019005737A (es) | Composicion farmaceutica para prevenir o tratar el cancer de cerebro que incluye polimorfocristalino de hexaoxido de tetraarsenico y metodo para preparar el mismo. | |
| MX389813B (es) | Composicion de mezcla maestra que comprende una elevada concentracion de entidades biologicas | |
| BRPI0705488A (pt) | composição nanoparticulada estável, métodos de preparar a mesma e de prevenir e/ou tratar uma infecção bacteriana, composição farmacêutica, e, forma de dosagem | |
| MX2017000578A (es) | Tratamiento de cancer con una combinacion de radiacion, nanoparticulas de oxido de cerio y un agente quimioterapeutico. | |
| EP3466882A4 (en) | METHOD FOR PRODUCING SILICONE COMPOUND COATED OXIDE PARTICLES, SILICONE COMPOUND COATED OXIDE PARTICLES, AND SILICONE COMPOUND COATED OXID COMPOSITION THEREWITH | |
| NZ705109A (en) | Antibody formulations and uses thereof | |
| BR112017025631A2 (pt) | composições oftálmicas aquosas, método de induzir ou aumentar a formação de lágrima, método de formação de aglomerados de ciclosporina a e uso de ciclosporina a | |
| AR103215A1 (es) | Composición farmacéutica que comprende plasminógeno y usos de este | |
| MX2016000131A (es) | Nanoparticulas polimericas de docetaxel para el tratamiento de cancer. | |
| EP3424877A4 (en) | SILVER-CONTAINING CALCIUM PHOSPHATE SINTERED BODY AND METHOD FOR THE PRODUCTION THEREOF | |
| EA201491691A1 (ru) | Агрегаты наночастиц, содержащие остеопонтин и кальций- и/или стронцийсодержащие частицы | |
| PH12016501863A1 (en) | Heteroaromatic compounds and their use as dopamine d1 ligands | |
| MX2019014310A (es) | Agente para prevenir o tratar atrofia cerebral. | |
| Wang et al. | A facile method to in situ formation of hydroxyapatite single crystal architecture for enhanced osteoblast adhesion | |
| MA46235B1 (fr) | 1-aryl-naphtyridin-3-ylcarboxamides substitués en position 7 et leur utilisation | |
| EP2949454A3 (en) | Hydrogels and medical devices with pure nano-particles embedded | |
| MX374165B (es) | Aducto de ciclodextrina-panobinostat | |
| ZA202004343B (en) | Nanoparticles for use in enhancing brain performances or in treating stress | |
| EA201890703A1 (ru) | Коллоидные частицы, предназначенные для применения в медицине | |
| EP3582757A4 (en) | AYURVEDIC ENCAPSULATED GOLD NANOPARTICLE, MANUFACTURING METHOD AND CANCER THERAPY METHOD | |
| EP3919585A4 (en) | QUANTUM-DOT CONTAINING NANOPARTICLES AND PROCESS FOR THE PRODUCTION THEREOF |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |